Agilon Health, Inc. (AGL)
82.39
-2.33
(-2.75%)
USD |
NYSE |
Oct 09, 16:00
82.42
+0.03
(+0.04%)
Pre-Market: 20:00
Agilon Health Cash from Operations (Quarterly) : -57.30M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -57.30M |
| March 31, 2026 | 22.12M |
| December 31, 2025 | -20.54M |
| September 30, 2025 | -18.15M |
| June 30, 2025 | -35.08M |
| March 31, 2025 | -31.99M |
| December 31, 2024 | 16.42M |
| September 30, 2024 | -7.703M |
| June 30, 2024 | -18.72M |
| March 31, 2024 | -47.78M |
| December 31, 2023 | -61.17M |
| September 30, 2023 | -13.02M |
| June 30, 2023 | -21.20M |
| Date | Value |
|---|---|
| March 31, 2023 | -60.81M |
| December 31, 2022 | -49.96M |
| September 30, 2022 | 2.647M |
| June 30, 2022 | -60.26M |
| March 31, 2022 | -23.23M |
| December 31, 2021 | -48.90M |
| September 30, 2021 | -19.14M |
| June 30, 2021 | -39.29M |
| March 31, 2021 | -40.83M |
| December 31, 2020 | -13.34M |
| September 30, 2020 | -4.367M |
| June 30, 2020 | -9.371M |
| March 31, 2020 | -26.13M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Astrana Health, Inc. | 32.75M |
| Starling Oncology, Inc. | 11.94M |
| Nakamoto, Inc. | -3.253M |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | -1.601M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 19.91M |
| Cash from Financing (Quarterly) | 4.631M |
| Free Cash Flow | -107.60M |
| Free Cash Flow Per Share (Quarterly) | -3.579 |
| Free Cash Flow to Equity (Quarterly) | -61.65M |
| Free Cash Flow to Firm (Quarterly) | -59.96M |
| Free Cash Flow Yield | -7.79% |